Document 0540
 DOCN  M9650540
 TI    Does the key to a successful HIV type 1 vaccine lie among the envelope
       sequences of infected individuals?
 DT    9605
 AU    Rencher SD; Slobod KS; Dawson DH; Lockey TD; Hurwitz JL; Department of
       Immunology, St. Jude Children's Research Hospital,; Memphis, Tennessee,
       USA.
 SO    AIDS Res Hum Retroviruses. 1995 Sep;11(9):1131-3. Unique Identifier :
       AIDSLINE +
 DE    Amino Acid Sequence  AIDS Vaccines/GENETICS/*IMMUNOLOGY  Gene Products,
       env/*GENETICS/*IMMUNOLOGY  Genes, env  Human  HIV Antibodies  HIV
       Envelope Protein gp120/GENETICS/IMMUNOLOGY  HIV
       Infections/IMMUNOLOGY/PREVENTION & CONTROL/VIROLOGY
       HIV-1/*GENETICS/*IMMUNOLOGY/ISOLATION & PURIF  Molecular Sequence Data
       Neutralization Tests  Peptide Fragments/GENETICS/IMMUNOLOGY  Support,
       Non-U.S. Gov't  Support, U.S. Gov't, P.H.S.  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).